Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Usefulness of the nCounter Analysis System to Monitor Immune-related Biomarkers in PBMCs During Anti-PD-1 Therapy.

Morisaki T, Kubo M, Umebayashi M, Yuan Y, Tsuyada A, Tanaka H, Koya N, Nakagawa S, Morisaki T, Nakamura M.

Anticancer Res. 2019 Aug;39(8):4517-4523. doi: 10.21873/anticanres.13628.

PMID:
31366554
2.

A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer.

Kumegawa K, Maruyama R, Yamamoto E, Ashida M, Kitajima H, Tsuyada A, Niinuma T, Kai M, Yamano HO, Sugai T, Tokino T, Shinomura Y, Imai K, Suzuki H.

Sci Rep. 2016 May 24;6:26699. doi: 10.1038/srep26699.

3.

Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.

Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J, Chow A, O'Connor ST, Li S, Chin AR, Somlo G, Palomares M, Li Z, Tremblay JR, Tsuyada A, Sun G, Reid MA, Wu X, Swiderski P, Ren X, Shi Y, Kong M, Zhong W, Chen Y, Wang SE.

Nat Cell Biol. 2015 Feb;17(2):183-94. doi: 10.1038/ncb3094. Epub 2015 Jan 26.

4.

Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer.

Harada T, Yamamoto E, Yamano HO, Nojima M, Maruyama R, Kumegawa K, Ashida M, Yoshikawa K, Kimura T, Harada E, Takagi R, Tanaka Y, Aoki H, Nishizono M, Nakaoka M, Tsuyada A, Niinuma T, Kai M, Shimoda K, Shinomura Y, Sugai T, Imai K, Suzuki H.

Cancer Prev Res (Phila). 2014 Oct;7(10):1002-10. doi: 10.1158/1940-6207.CAPR-14-0162. Epub 2014 Aug 19.

5.

Fibroblast-derived CCL2 induces cancer stem cells--response.

Tsuyada A, Wang SE.

Cancer Res. 2013 Jan 15;73(2):1032-3. doi: 10.1158/0008-5472.CAN-12-3194. Epub 2013 Jan 10. No abstract available.

6.

Nuclear translocation of type I transforming growth factor β receptor confers a novel function in RNA processing.

Chandra M, Zang S, Li H, Zimmerman LJ, Champer J, Tsuyada A, Chow A, Zhou W, Yu Y, Gao H, Ren X, Lin RJ, Wang SE.

Mol Cell Biol. 2012 Jun;32(12):2183-95. doi: 10.1128/MCB.00320-12. Epub 2012 Apr 2.

7.

CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.

Tsuyada A, Chow A, Wu J, Somlo G, Chu P, Loera S, Luu T, Li AX, Wu X, Ye W, Chen S, Zhou W, Yu Y, Wang YZ, Ren X, Li H, Scherle P, Kuroki Y, Wang SE.

Cancer Res. 2012 Jun 1;72(11):2768-79. doi: 10.1158/0008-5472.CAN-11-3567. Epub 2012 Apr 3.

8.

Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.

Wang Y, Yu Y, Tsuyada A, Ren X, Wu X, Stubblefield K, Rankin-Gee EK, Wang SE.

Oncogene. 2011 Mar 24;30(12):1470-80. doi: 10.1038/onc.2010.531. Epub 2010 Nov 22.

9.

Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells.

Yu Y, Wang Y, Ren X, Tsuyada A, Li A, Liu LJ, Wang SE.

Mol Cancer Res. 2010 Dec;8(12):1633-42. doi: 10.1158/1541-7786.MCR-10-0362. Epub 2010 Oct 14.

Supplemental Content

Loading ...
Support Center